PRISTIQ ER 25 MG TABLET
FDA nonproprietary name: desvenlafaxine succinate
For 30 tablets
Pharmacies pay
$419.19 filed
30 × $13.973 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare
We don’t know yet
No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.
The spread
We don’t know yet
There is no Medicare figure to compare with, so there is no spread.
Cost-plus estimate
$487.07 estimated
$419.19 + $62.88 (15%) + $5.00 fee per fill = $487.07
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
PRISTIQ ER 25 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as desvenlafaxine succinate, under the trade name “Pristiq Extended-Release”.
FDA gives its dosage form as tablet, extended release and its route as oral.
The labeler, the company named on the label, is Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
FDA’s Established Pharmacologic Class for it is Serotonin and Norepinephrine Reuptake Inhibitor.
The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 00008-1210-30.
NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $419.19 for 30 tablets (30 × $13.973 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
NADAC also lists, on the row of one brand NDC, what pharmacies pay for the generic equivalent, a different product: $0.39851 per EA filed.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What NADAC measures · Why 30 tablets · NADAC explanation codes
The NDC
- 00008-1210-30 · Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. · $13.973 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
5 other products in the NADAC file share the FDA nonproprietary name desvenlafaxine succinate with PRISTIQ ER 25 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| DESVENLAFAXINE SUCCNT ER 25 MG | $0.39851 per EA filed | $1.19746 per EA filed |
| DESVENLAFAXINE SUCCNT ER 50 MG | $0.39649 per EA filed | $1.19746 per EA filed |
| DESVENLAFAXINE SUCCNT ER 100 MG | $0.4136 per EA filed | $1.19746 per EA filed |
| PRISTIQ ER 25 MG TABLET this page | $13.973 per EA filed | We don’t know yet |
| PRISTIQ ER 50 MG TABLET | $13.96336 per EA filed | We don’t know yet |
| PRISTIQ ER 100 MG TABLET | $13.93397 per EA filed | We don’t know yet |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
Its NADAC price is $13.973 per EA filed.
Of the 43 other products in FDA’s Serotonin and Norepinephrine Reuptake Inhibitor class priced per EA, 7 have a higher middle NADAC price and 36 a lower one. The one in the middle is MILNACIPRAN HCL 50 MG TABLET, at $2.80179 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
We don’t know yet; the card above says why.
Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- Is a generic version available, and would it suit me? NADAC lists a generic with the same ingredient, strength and dosage form by FDA: DESVENLAFAXINE SUCCNT ER 25 MG. Ask your pharmacist or prescriber; do not switch on your own.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Related pages
Its pharmacologic class
Related in the same class
- DULOXETINE HCL DR 20 MG CAP
- VENLAFAXINE HCL ER 150 MG TAB
- SAVELLA 100 MG TABLET
- DESVENLAFAXINE ER 100 MG TAB
- FETZIMA ER 120 MG CAPSULE